What is CNL HEALTHCARE PPTYS INC's earnings per share (EPS)?

CNL HEALTHCARE PPTYS INC (CHTH) reported diluted earnings per share of -$0.08 for fiscal year 2024. This represents a 46.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

CNL HEALTHCARE PPTYS INC (CHTH) Financials

CHTH

Trailing 12 months to September 30, 2025

Revenue $385.5M +7.3% YoY

Net Income -$10.6M +43.2% YoY

EPS (Diluted) -$0.06 +45.5% YoY

Operating Cash Flow $53.2M +38.9% YoY

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Sep 30, 2025 Reported Nov 13, 2025 Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2025, filed Nov 13, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CHTH SEC filings page.

CNL HEALTHCARE PPTYS INC (CHTH) reported $385.5M in revenue over the twelve months to Sep 30, 2025, up 7.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CHTH FY2024 2026-08-30

Operational improvement is increasingly visible, but depreciation and interest keep reported earnings below recurring cash generation.

The operating margin nearly doubled from FY2023 to FY2024 while revenue rose 7.2%, pointing to better cost absorption rather than mere top-line expansion. FY2024 operating cash flow stayed positive despite a net loss, and $50.7M of depreciation and amortization helps explain why accounting earnings understate cash generated by the asset base.

Debt declined in FY2024 even as assets declined, so balance-sheet shrinkage—not incremental borrowing—accompanied the operating improvement. Equity fell while debt-to-equity reached 0.8x, meaning lower debt in dollars did not reduce leverage relative to the capital base.

Operating cash flow increased from $32.0M to $40.3M while dividends remained below that flow, indicating distributions were not the main cash use. The same period lifted EBITDA from $64.9M to $81.6M, so the recovery appeared in both operating earnings and cash rather than only in accounting adjustments.

Financial Health Signals

Financial health score not available

CNL HEALTHCARE PPTYS INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

5/7

CNL HEALTHCARE PPTYS INC passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

N/A

CNL HEALTHCARE PPTYS INC reported a net loss of $14.5M while generating $40.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.67x

CNL HEALTHCARE PPTYS INC earns $0.67 in operating income for every $1 of interest expense ($30.9M vs $45.9M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$99.3M

YoY+7.0%

QoQ+2.0%

5Y CAGR+5.4%

10Y CAGR+2.2%

CNL HEALTHCARE PPTYS INC generated $99.3M in revenue in Q3 2025. This represents an increase of 7.0% from the same quarter a year earlier. Against the prior quarter it is up 2.0%.

EBITDA

$22.3M

YoY+7.6%

QoQ-1.8%

5Y CAGR+5.2%

10Y CAGR+1.1%

CNL HEALTHCARE PPTYS INC's EBITDA was $22.3M in Q3 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 7.6% from the same quarter a year earlier. Against the prior quarter it is down 1.8%.

Net Income

-$1.6M

YoY+50.3%

QoQ-5.8%

CNL HEALTHCARE PPTYS INC reported -$1.6M in net income in Q3 2025. This represents an increase of 50.3% from the same quarter a year earlier. Against the prior quarter it is down 5.8%.

EPS (Diluted)

-$0.01

YoY+50.0%

QoQ0.0%

CNL HEALTHCARE PPTYS INC earned -$0.01 per diluted share (EPS) in Q3 2025. This represents an increase of 50.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Cash & Balance Sheet

Cash & Debt

$57.7M

YoY+14.2%

QoQ+8.5%

5Y CAGR-3.8%

10Y CAGR+1.2%

CNL HEALTHCARE PPTYS INC held $57.7M in cash against $565.0M in long-term debt as of Q3 2025.

Dividends Per Share

$0.03

YoY0.0%

QoQ0.0%

5Y CAGR-12.9%

CNL HEALTHCARE PPTYS INC paid $0.03 per share in dividends in Q3 2025. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

175M

YoY0.0%

QoQ0.0%

5Y CAGR+0.2%

10Y CAGR+0.1%

CNL HEALTHCARE PPTYS INC had 175M shares outstanding in Q3 2025. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q3 2025.

Margins & Returns

Operating Margin

9.5%

YoY+0.7pp

QoQ-0.3pp

5Y change+5.7pp

10Y change+19.4pp

CNL HEALTHCARE PPTYS INC's operating margin was 9.5% in Q3 2025, reflecting core business profitability. This is up 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.3 percentage points.

Net Margin

-1.6%

YoY+1.8pp

QoQ-0.1pp

5Y change+0.7pp

10Y change+22.5pp

CNL HEALTHCARE PPTYS INC's net profit margin was -1.6% in Q3 2025, showing the share of revenue converted to profit. This is up 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.1 percentage points.

Return on Equity

-0.2%

YoY+0.2pp

QoQ0.0pp

5Y change0.0pp

10Y change+1.3pp

CNL HEALTHCARE PPTYS INC's ROE was -0.2% in Q3 2025, measuring profit generated per dollar of shareholder equity. This is up 0.2 percentage points from the same quarter a year earlier. It is unchanged from the prior quarter.

Gross Margin

Not reported for Q3 2025.

Capital Allocation

None of these metrics is reported for Q3 2025.

CHTH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CHTH quarterly income statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$385.5M	$366.0M+7.2%	$341.5M+5.8%	$322.7M+9.2%	$295.4M-3.8%	$307.1M-5.8%	$326.1M+3.8%	$314.1M+10.3%	$284.7M+7.4%	$265.2M-11.8%	$300.5M+66.0%	$181.1M+244.2%	$52.6M+612.3%	$7.4M	N/A
SG&A Expenses	$9.6M	$8.8M-3.8%	$9.1M-10.9%	$10.2M+12.0%	$9.1M-3.2%	$9.4M-28.8%	$13.2M+2.6%	$12.9M+8.0%	$11.9M-0.1%	$11.9M+18.3%	$10.1M+46.7%	$6.9M+22.4%	$5.6M+119.2%	$2.6M+194.6%	$870K
Operating Income	$33.8M	$30.9M+126.3%	$13.7M+54.0%	$8.9M+5111.3%	-$177K-100.8%	$21.7M-47.8%	$41.6M+109.9%	$19.8M+130.9%	$8.6M+20.1%	$7.2M+129.4%	-$24.3M-4.9%	-$23.2M-65.7%	-$14.0M-131.5%	-$6.0M-243.0%	-$1.8M
EBITDA	N/A	$81.6M+25.7%	$64.9M+2.8%	$63.1M+25.6%	$50.2M-31.7%	$73.6M-19.6%	$91.5M+22.7%	$74.5M+2.1%	$73.0M-13.9%	$84.7M+3.8%	$81.6M+104.4%	$39.9M+1339.1%	$2.8M+170.4%	-$3.9M	N/A
Interest Expense	$44.3M	$45.9M+9.5%	$41.9M+92.2%	$21.8M+10.6%	$19.7M-18.9%	$24.3M-38.7%	$39.6M-7.4%	$42.8M+18.6%	$36.1M+12.7%	$32.0M-25.4%	$43.0M+40.9%	$30.5M+182.3%	$10.8M+84.6%	$5.8M	N/A
Income Tax	$745K	$611K+9.1%	$560K+3.7%	$540K-87.1%	$4.2M+280.1%	$1.1M-50.3%	$2.2M-39.3%	$3.6M+143.2%	-$8.4M-3157.2%	$276K-27.0%	$378K+4.7%	$361K+1905.6%	$18K+205.9%	-$17K	N/A
Net Income	-$10.6M	-$14.5M+43.7%	-$25.7M-1668.6%	-$1.5M+93.7%	-$22.9M-684.9%	$3.9M-98.9%	$351.5M+1501.9%	-$25.1M+3.4%	-$26.0M+18.0%	-$31.7M+53.5%	-$68.1M-29.6%	-$52.5M-190.1%	-$18.1M-68.8%	-$10.7M-509.1%	-$1.8M
EPS (Basic)	N/A	-$0.08+46.7%	-$0.15-1400.0%	-$0.01+92.3%	-$0.13-1400.0%	$0.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	-$0.06	-$0.08+46.7%	-$0.15-1400.0%	-$0.01+92.3%	-$0.13	$0.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	174M0.0%	174M0.0%	174M0.0%	174M	174M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Revenue	$99.3M+7.0%	$97.4M+7.1%	$95.6M+7.4%	$93.2M+7.8%	$92.8M+7.6%	$90.9M+6.7%	$89.1M+6.5%	$86.4M+6.0%
SG&A Expenses	$2.5M+37.8%	$2.2M-0.6%	$2.3M+5.4%	$2.5M-0.9%	$1.8M-8.6%	$2.2M-5.0%	$2.2M-1.2%	$2.5M+5.2%
Operating Income	$9.4M+15.8%	$9.6M-4.9%	$8.5M+33.7%	$6.4M+270.1%	$8.1M+63.6%	$10.0M+144.5%	$6.3M+122.5%	$1.7M+116.8%
EBITDA	$22.3M+7.6%	$22.7M+0.3%	$21.2M+12.3%	$19.3M+35.7%	$20.8M+19.0%	$22.7M+33.7%	$18.9M+16.0%	$14.2M-0.4%
Interest Expense	$10.9M-5.1%	$11.0M-3.5%	$11.0M-5.3%	$11.3M+0.9%	$11.5M+7.1%	$11.4M+11.5%	$11.6M+20.1%	$11.2M+57.6%
Income Tax	$181K+44.8%	$154K+25.2%	$162K+40.9%	$248K+3.8%	$125K+5.9%	$123K+33.7%	$115K+3.6%	$239K-25.1%
Net Income	-$1.6M+50.3%	-$1.5M-14.6%	-$2.6M+49.0%	-$5.0M+45.7%	-$3.2M+41.4%	-$1.3M+75.5%	-$5.0M+13.9%	-$9.1M-50.0%
EPS (Basic)	-$0.01+50.0%	-$0.010.0%	-$0.01+66.7%	-$0.03+40.0%	-$0.02+33.3%	-$0.01+66.7%	-$0.030.0%	-$0.05-25.0%
EPS (Diluted)	-$0.01+50.0%	-$0.010.0%	-$0.01	-$0.03+40.0%	-$0.02+33.3%	-$0.01+66.7%	-$0.030.0%	-$0.05-25.0%
Diluted Shares (Avg)	174M0.0%	174M0.0%	174M	N/A	174M0.0%	174M0.0%	174M0.0%	N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.

CHTH Balance Sheet

CHTH quarterly balance sheet

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$1.3B-3.4%	$1.4B-5.0%	$1.4B+0.1%	$1.4B-4.5%	$1.5B-7.0%	$1.6B-40.3%	$2.7B-3.1%	$2.8B-1.2%	$2.8B-0.1%	$2.8B+42.3%	$2.0B+96.1%	$1.0B+200.2%	$337.8M+3097.7%	$10.6M
Cash & Equivalents	$44.0M-18.6%	$54.1M-22.2%	$69.5M+30.7%	$53.2M-13.5%	$61.5M+45.2%	$42.4M-25.8%	$57.1M-11.5%	$64.5M+10.3%	$58.5M-15.1%	$68.9M-24.6%	$91.4M+106.6%	$44.2M+142.1%	$18.3M+82.6%	$10.0M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$607.6M-2.2%	$621.5M-3.9%	$647.0M+3.4%	$625.8M-1.4%	$634.7M-11.3%	$715.4M-59.4%	$1.8B+1.3%	$1.7B+4.1%	$1.7B+6.4%	$1.6B+40.8%	$1.1B+98.7%	$562.1M+185.1%	$197.1M+22798.3%	$861K
Long-Term Debt	$569.9M-2.6%	$584.8M-4.1%	$609.9M+2.9%	$592.8M-1.6%	$602.5M-11.7%	$682.3M-28.9%	$959.7M-42.6%	$1.7B+5.2%	$1.6B+6.8%	$1.5B+40.4%	$1.1B+97.5%	$536.6M+177.8%	$193.2M	N/A
Total Equity	$711.8M-4.3%	$743.6M-5.8%	$789.8M-2.4%	$809.0M-6.7%	$867.5M-3.5%	$899.2M-4.4%	$940.3M-10.5%	$1.1B-8.8%	$1.2B-8.3%	$1.3B+44.3%	$871.2M+92.7%	$452.0M+221.3%	$140.7M+1349.7%	$9.7M
Retained Earnings	$60.2M-19.4%	$74.7M-25.6%	$100.4M-1.4%	$101.9M-18.3%	$124.7M+3.2%	$120.8M+151.7%	-$233.8M-12.0%	-$208.8M-14.2%	-$182.8M-21.0%	-$151.1M-81.9%	-$83.1M-171.7%	-$30.6M-145.0%	-$12.5M-609.3%	-$1.8M

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Total Assets	$1.3B-2.5%	$1.3B-2.8%	$1.3B-2.4%	$1.3B-3.4%	$1.3B-3.5%	$1.3B-3.7%	$1.3B-4.0%	$1.4B-5.0%
Cash & Equivalents	$57.7M+14.2%	$53.2M+8.4%	$50.9M+20.3%	$44.0M-18.6%	$50.5M-5.6%	$49.1M-0.3%	$42.4M-3.7%	$54.1M-22.2%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$608.1M-1.1%	$603.1M-0.7%	$608.6M+0.2%	$607.6M-2.2%	$614.7M-1.4%	$607.3M-2.3%	$607.3M-2.3%	$621.5M-3.9%
Long-Term Debt	$565.0M-1.6%	$565.0M-1.6%	$570.0M-0.8%	$569.9M-2.6%	$574.2M-1.9%	$574.4M-1.9%	$574.6M-1.8%	$584.8M-4.1%
Total Equity	$693.6M-3.7%	$699.5M-4.5%	$704.9M-4.4%	$711.8M-4.3%	$720.1M-5.2%	$732.3M-4.9%	$737.6M-5.3%	$743.6M-5.8%
Retained Earnings	$54.6M-16.2%	$56.2M-17.8%	$57.7M-17.2%	$60.2M-19.4%	$65.2M-22.2%	$68.4M-23.4%	$69.7M-26.3%	$74.7M-25.6%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities, Non-Current Liabilities.

CHTH Cash Flow Statement

CHTH quarterly cash flow statement

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$53.2M	$40.3M+26.1%	$32.0M-27.1%	$43.8M-5.4%	$46.4M-26.5%	$63.1M+5.3%	$60.0M-10.9%	$67.3M-10.6%	$75.2M+1.0%	$74.5M+71.3%	$43.5M+125.8%	$19.3M+532.7%	$3.0M+147.8%	-$6.4M-487.0%	-$1.1M
Depreciation & Amortization	N/A	$50.7M-1.1%	$51.2M-5.5%	$54.2M+7.6%	$50.4M-2.7%	$51.8M+4.0%	$49.8M-8.9%	$54.7M-15.1%	$64.4M-17.0%	$77.6M-26.8%	$105.9M+67.9%	$63.1M+276.5%	$16.8M+698.0%	$2.1M	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$9.8M+827.0%	$1.1M-96.2%	$28.1M-96.8%	$866.3M-0.4%	$869.5M+32.6%	$655.9M+171.3%	$241.8M	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$57.5M-22.5%	$74.2M+59.7%	$46.4M+105.6%	-$822.8M+3.2%	-$850.2M-30.2%	-$652.9M-163.1%	-$248.2M	N/A
Investing Cash Flow	-$18.2M	-$16.1M-274.5%	$9.3M+249.6%	-$6.2M+8.3%	-$6.7M-109.7%	$69.9M-94.8%	$1.4B+9511.3%	-$14.4M+77.7%	-$64.5M+35.1%	-$99.4M	N/A	N/A	-$643.8M-104.0%	-$315.6M-78811.8%	-$400K
Financing Cash Flow	-$28.5M	-$34.4M+41.5%	-$58.9M-170.6%	-$21.8M+54.6%	-$47.9M+58.5%	-$115.6M+91.9%	-$1.4B-2204.6%	-$62.1M-756.3%	-$7.2M-142.8%	$16.9M	N/A	N/A	$666.7M+101.9%	$330.3M+2826.4%	$11.3M
Dividends Paid	$17.8M	$17.8M0.0%	$17.8M0.0%	$17.8M-50.0%	$35.6M0.0%	$35.6M-91.0%	$394.9M+568.7%	$59.1M+71.1%	$34.5M+9.7%	$31.5M+19.3%	$26.4M+85.7%	$14.2M+115.9%	$6.6M+350.9%	$1.5M+5110.7%	$28K
Share Buybacks	N/A	N/A	N/A	N/A	$0	$0-100.0%	$23K-99.9%	$40.2M-12.7%	$46.0M+61.0%	$28.6M+284.2%	$7.4M+231.3%	$2.2M+218.1%	$706K+6960.0%	$10K	N/A

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Operating Cash Flow	$13.4M+30.2%	$16.2M+19.7%	$14.3M+100.1%	$9.3M+27.1%	$10.3M+31.0%	$13.5M+18.3%	$7.1M+34.2%	$7.3M-22.4%
Depreciation & Amortization	$12.9M+2.2%	$13.2M+4.4%	$12.7M+1.5%	$12.9M+3.3%	$12.6M+1.2%	$12.6M-1.7%	$12.5M-6.6%	$12.5M-7.3%
Investing Cash Flow	-$4.4M-25.2%	-$4.5M-50.6%	-$2.3M+14.8%	-$7.0M-172.7%	-$3.5M-410.3%	-$3.0M-53.6%	-$2.7M-661.9%	$9.6M+132.2%
Financing Cash Flow	-$4.5M+6.8%	-$9.5M-102.4%	-$4.3M+70.4%	-$10.3M+38.5%	-$4.8M-0.3%	-$4.7M+10.0%	-$14.7M+54.4%	-$16.7M-233.9%
Dividends Paid	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%	$4.5M0.0%

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Share Buybacks.

CHTH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CHTH quarterly financial ratios

Metric	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	8.5%+4.5pp	4.0%+1.3pp	2.8%+2.8pp	-0.1%-7.1pp	7.1%-5.7pp	12.8%+6.5pp	6.3%+3.3pp	3.0%+0.3pp	2.7%+10.8pp	-8.1%+4.7pp	-12.8%+13.8pp	-26.6%+55.2pp	-81.8%	N/A
Net Margin	-4.0%+3.6pp	-7.5%-7.1pp	-0.4%+7.3pp	-7.8%-9.0pp	1.3%	107.8%	-8.0%+1.1pp	-9.1%+2.8pp	-11.9%+10.7pp	-22.7%+6.3pp	-29.0%+5.4pp	-34.4%	-145.2%	N/A
Return on Equity	-2.0%+1.4pp	-3.5%-3.3pp	-0.2%+2.6pp	-2.8%-3.3pp	0.4%-38.6pp	39.1%+41.8pp	-2.7%-0.2pp	-2.5%+0.3pp	-2.8%+2.7pp	-5.4%+0.6pp	-6.0%-2.0pp	-4.0%+3.6pp	-7.6%+10.5pp	-18.1%
Return on Assets	-1.1%+0.8pp	-1.9%-1.8pp	-0.1%+1.5pp	-1.6%-1.9pp	0.3%-21.5pp	21.8%+22.7pp	-0.9%0.0pp	-0.9%+0.2pp	-1.1%+1.3pp	-2.4%+0.2pp	-2.6%-0.9pp	-1.8%+1.4pp	-3.2%+13.5pp	-16.7%
Debt-to-Equity	0.800.0x	0.790.0x	0.770.0x	0.730.0x	0.69-0.1x	0.76-0.3x	1.02-0.6x	1.59+0.2x	1.38+0.2x	1.180.0x	1.220.0x	1.19-0.2x	1.37+1.3x	0.09
Asset Turnover	0.280.0x	0.250.0x	0.220.0x	0.210.0x	0.200.0x	0.20+0.1x	0.120.0x	0.100.0x	0.090.0x	0.110.0x	0.090.0x	0.050.0x	0.02	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	18.3%-7.8pp	26.1%+8.5pp	17.5%	-273.8%	-469.5%	-1241.1%	-3360.5%	N/A

Metric	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K
Operating Margin	9.5%+0.7pp	9.8%-1.2pp	8.8%+1.7pp	6.9%+4.9pp	8.8%+3.0pp	11.1%+6.2pp	7.1%+3.7pp	2.0%+1.0pp
Net Margin	-1.6%+1.8pp	-1.5%-0.1pp	-2.7%+3.0pp	-5.3%+5.2pp	-3.4%+2.9pp	-1.4%+4.8pp	-5.7%+1.3pp	-10.5%-3.1pp
Return on Equity	-0.2%+0.2pp	-0.2%0.0pp	-0.4%+0.3pp	-0.7%+0.5pp	-0.4%+0.3pp	-0.2%+0.5pp	-0.7%+0.1pp	-1.2%-0.5pp
Return on Assets	-0.1%+0.1pp	-0.1%0.0pp	-0.2%+0.2pp	-0.4%+0.3pp	-0.2%+0.1pp	-0.1%+0.3pp	-0.4%0.0pp	-0.7%-0.3pp
Debt-to-Equity	0.810.0x	0.810.0x	0.810.0x	0.800.0x	0.800.0x	0.780.0x	0.780.0x	0.790.0x
Asset Turnover	0.080.0x	0.070.0x	0.070.0x	0.070.0x	0.070.0x	0.070.0x	0.070.0x	0.060.0x

Not reported in any period shown, so not listed: Gross Margin, Current Ratio, FCF Margin.

Where CNL HEALTHCARE PPTYS INC Ranks

Frequently Asked Questions

What is CNL HEALTHCARE PPTYS INC's annual revenue?

CNL HEALTHCARE PPTYS INC (CHTH) reported $366.0M in total revenue for fiscal year 2024. This represents a 7.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is CNL HEALTHCARE PPTYS INC's revenue growing?

CNL HEALTHCARE PPTYS INC (CHTH) revenue grew by 7.2% year-over-year, from $341.5M to $366.0M in fiscal year 2024.

Is CNL HEALTHCARE PPTYS INC profitable?

No, CNL HEALTHCARE PPTYS INC (CHTH) reported a net income of -$14.5M in fiscal year 2024, with a net profit margin of -4.0%.

What is CNL HEALTHCARE PPTYS INC's EBITDA?

CNL HEALTHCARE PPTYS INC (CHTH) had EBITDA of $81.6M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does CNL HEALTHCARE PPTYS INC have?

As of fiscal year 2024, CNL HEALTHCARE PPTYS INC (CHTH) had $44.0M in cash and equivalents against $569.9M in long-term debt.

What is CNL HEALTHCARE PPTYS INC's operating margin?

CNL HEALTHCARE PPTYS INC (CHTH) had an operating margin of 8.5% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is CNL HEALTHCARE PPTYS INC's net profit margin?

CNL HEALTHCARE PPTYS INC (CHTH) had a net profit margin of -4.0% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Does CNL HEALTHCARE PPTYS INC pay dividends?

Yes, CNL HEALTHCARE PPTYS INC (CHTH) paid $0.10 per share in dividends during fiscal year 2024.

What is CNL HEALTHCARE PPTYS INC's return on equity (ROE)?

CNL HEALTHCARE PPTYS INC (CHTH) has a return on equity of -2.0% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

What is CNL HEALTHCARE PPTYS INC's operating cash flow?

CNL HEALTHCARE PPTYS INC (CHTH) generated $40.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are CNL HEALTHCARE PPTYS INC's total assets?

CNL HEALTHCARE PPTYS INC (CHTH) had $1.3B in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does CNL HEALTHCARE PPTYS INC have outstanding?

CNL HEALTHCARE PPTYS INC (CHTH) had 175M shares outstanding as of fiscal year 2024.

What is CNL HEALTHCARE PPTYS INC's debt-to-equity ratio?

CNL HEALTHCARE PPTYS INC (CHTH) had a debt-to-equity ratio of 0.80 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is CNL HEALTHCARE PPTYS INC's return on assets (ROA)?

CNL HEALTHCARE PPTYS INC (CHTH) had a return on assets of -1.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is CNL HEALTHCARE PPTYS INC's Piotroski F-Score?

CNL HEALTHCARE PPTYS INC (CHTH) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are CNL HEALTHCARE PPTYS INC's earnings high quality?

CNL HEALTHCARE PPTYS INC (CHTH) reported a net loss of $14.5M while generating $40.3M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can CNL HEALTHCARE PPTYS INC cover its interest payments?

CNL HEALTHCARE PPTYS INC (CHTH) has an interest coverage ratio of 0.67x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.